| 365 |
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside A) |
FDA has no questions |
| 364 |
Bacteriophages LAND12, OLB1, TSRW1, DSMP1, DP1 |
At notifier's request, FDA ceased to evaluate the notice |
| 363 |
Calcium disodium ethylenediaminetetraacetic acid (EDTA) and disodium EDTA |
FDA has no questions |
| 362 |
Levocarnitine |
At notifier's request, FDA ceased to evaluate the notice |
| 361 |
1,4-α-D-glucan branching enzyme preparation |
At notifier's request, FDA ceased to evaluate the notice |
| 360 |
Hydrolyzed sardine protein |
FDA has no questions |
| 359 |
Siraitia grosvenorii Swingle (Luo Han Guo) fruit extracts (SGFE) |
FDA has no questions |
| 358 |
Cyclic dextrin, highly branched |
At notifier's request, FDA ceased to evaluate the notice |
| 357 |
Lactobacillus acidophilus NCFM |
FDA has no questions |
| 356 |
Haematococcus pluvialis extract containing astaxanthin esters |
At notifier's request, FDA ceased to evaluate the notice |
| 355 |
Eicosapentaenoic acid (EPA)-rich triglyceride oil from Yarrowia lipolytica |
FDA has no questions |
| 354 |
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside A) |
FDA has no questions |
| 353 |
High-selenium yeast |
FDA has no questions |
| 352 |
D-Tagatose |
FDA has no questions |
| 351 |
Dunaliella bardawil |
FDA has no questions |
| 350 |
Saccharomyces cerevisiae strain P1Y0, a variant of S. cerevisiae parent strain UCD2034 |
FDA has no questions |
| 349 |
Purified steviol glycosides with rebaudioside A and stevioside as the principal components |
FDA has no questions |
| 348 |
Stevioside purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (stevioside) |
FDA has no questions |
| 347 |
Caffeine |
At notifier's request, FDA ceased to evaluate the notice |
| 346 |
Freeze-dried fruit gac powder |
At notifier's request, FDA ceased to evaluate the notice |
| 345 |
Carboxypeptidase enzyme preparation from modified Aspergillus niger |
FDA has no questions |
| 344 |
Barley fiber |
FDA has no questions |
| 343 |
Wheat bran extract composed primarily of xylo- and arabinoxylo-oligosaccharides |
FDA has no questions |
| 342 |
Oat hull fiber |
FDA has no questions |
| 341 |
Quercetin |
FDA has no questions; some uses may require a color additive listing |
| 340 |
Theobromine |
At notifier's request, FDA ceased to evaluate the notice |
| 339 |
Polyglutamic acid |
FDA has no questions |
| 338 |
L-theanine extracted from tea leaves (Camellia sinensis) |
FDA has no questions |
| 337 |
Enzyme-modified steviol glycosides preparation (EMSGP) |
FDA has no questions |
| 336 |
ε-Polylysine (polylysine) |
FDA has no questions |
| 335 |
Pine tree phytosterol esters |
FDA has no questions |
| 334 |
Galacto-oligosaccharides |
FDA has no questions |
| 333 |
Acid fungal protease enzyme preparation from Trichoderma reesei expressing the gene encoding acid fungal protease from T. reesei |
FDA has no questions |
| 332 |
Oil from the seeds of the Korean pine (Pinus koraiensis) (Korean-pine nut oil) |
FDA has no questions |
| 331 |
Algal oil (Chlorella protothecoides) |
At notifier's request, FDA ceased to evaluate the notice |
| 330 |
Algal flour (Chlorella protothecoides) |
At notifier's request, FDA ceased to evaluate the notice |
| 329 |
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni |
FDA has no questions |
| 328 |
Polysaccharide complex of konjac glucomannan (konjac), sodium alginate, and xanthan gum (polysaccharide complex KAX) |
Notice does not provide a basis for a GRAS determination. |
| 327 |
Cruciferin-rich canola/rapeseed protein isolate and napin-rich canola/rapeseed protein isolate |
FDA has no questions |
| 326 |
Arachidonic acid rich oil from M. alpina strain I49-N18 |
FDA has no questions |
| 325 |
Olestra |
FDA has no questions |
| 324 |
Heat-killed Lactobacillus plantarum |
At notifier's request, FDA ceased to evaluate the notice |
| 323 |
Purified steviol glycosides with rebaudioside A and stevioside as the principal components |
FDA has no questions |
| 322 |
Aqueous extract of Emblica officinalis |
At notifier's request, FDA ceased to evaluate the notice |
| 321 |
Synthetic amorphous silica |
FDA has no questions |
| 320 |
Palm oil-derived carotenoids with β-carotene, α-carotene, γ-carotene, and lycopene |
FDA has no questions; some uses may require a color additive listing |
| 319 |
Micro-algal oil Ulkenia sp. SAM2179 |
FDA has no questions; some uses may require a color additive listing |
| 318 |
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni |
FDA has no questions |
| 317 |
L-arginine |
FDA has no questions |
| 316 |
Sodium potassium hexametaphosphate |
FDA has no questions |